JP2008530045A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008530045A5 JP2008530045A5 JP2007554500A JP2007554500A JP2008530045A5 JP 2008530045 A5 JP2008530045 A5 JP 2008530045A5 JP 2007554500 A JP2007554500 A JP 2007554500A JP 2007554500 A JP2007554500 A JP 2007554500A JP 2008530045 A5 JP2008530045 A5 JP 2008530045A5
- Authority
- JP
- Japan
- Prior art keywords
- alk
- optionally substituted
- compound according
- alkyl
- heterocyclyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims 58
- 125000001424 substituent group Chemical group 0.000 claims 20
- 229910052799 carbon Inorganic materials 0.000 claims 18
- 229910052739 hydrogen Inorganic materials 0.000 claims 16
- 125000005843 halogen group Chemical group 0.000 claims 15
- 125000000623 heterocyclic group Chemical group 0.000 claims 13
- -1 difluoro-substituted phenyl Chemical group 0.000 claims 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 8
- 229920006395 saturated elastomer Polymers 0.000 claims 8
- 229910003827 NRaRb Inorganic materials 0.000 claims 7
- 125000004043 oxo group Chemical group O=* 0.000 claims 7
- 125000004452 carbocyclyl group Chemical group 0.000 claims 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 4
- KWEDUNSJJZVRKR-UHFFFAOYSA-N carbononitridic azide Chemical compound [N-]=[N+]=NC#N KWEDUNSJJZVRKR-UHFFFAOYSA-N 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 3
- PQIOSYKVBBWRRI-UHFFFAOYSA-N methylphosphonyl difluoride Chemical group CP(F)(F)=O PQIOSYKVBBWRRI-UHFFFAOYSA-N 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 125000004076 pyridyl group Chemical group 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical group C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 claims 2
- 125000003373 pyrazinyl group Chemical group 0.000 claims 2
- 125000002098 pyridazinyl group Chemical group 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- 125000004776 1-fluoroethyl group Chemical group [H]C([H])([H])C([H])(F)* 0.000 claims 1
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 claims 1
- JQCSUVJDBHJKNG-UHFFFAOYSA-N 1-methoxy-ethyl Chemical group C[CH]OC JQCSUVJDBHJKNG-UHFFFAOYSA-N 0.000 claims 1
- 208000031886 HIV Infections Diseases 0.000 claims 1
- 208000037357 HIV infectious disease Diseases 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 150000001721 carbon Chemical group 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N diethylenediamine Chemical group C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 claims 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000006413 ring segment Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0500307 | 2005-02-10 | ||
| SE0502352 | 2005-10-25 | ||
| SE0502468 | 2005-11-08 | ||
| PCT/EP2006/001135 WO2006084688A1 (en) | 2005-02-10 | 2006-02-09 | HIV protease inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008530045A JP2008530045A (ja) | 2008-08-07 |
| JP2008530045A5 true JP2008530045A5 (enExample) | 2009-03-26 |
Family
ID=36128513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007554500A Withdrawn JP2008530045A (ja) | 2005-02-10 | 2006-02-09 | Ｈｉｖプロテアーゼインヒビター |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7807677B2 (enExample) |
| EP (1) | EP1851193B1 (enExample) |
| JP (1) | JP2008530045A (enExample) |
| KR (1) | KR20070110847A (enExample) |
| AP (1) | AP2007004079A0 (enExample) |
| AT (1) | ATE429417T1 (enExample) |
| AU (1) | AU2006212422B2 (enExample) |
| BR (1) | BRPI0607230A2 (enExample) |
| CA (1) | CA2594395A1 (enExample) |
| DE (1) | DE602006006418D1 (enExample) |
| EA (1) | EA013520B1 (enExample) |
| ES (1) | ES2326041T3 (enExample) |
| IL (1) | IL183850A (enExample) |
| MX (1) | MX2007009655A (enExample) |
| PL (1) | PL1851193T3 (enExample) |
| WO (1) | WO2006084688A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006212422B2 (en) | 2005-02-10 | 2011-08-18 | Medivir Ab | HIV protease inhibitors |
| WO2007048557A1 (en) * | 2005-10-25 | 2007-05-03 | Medivir Ab | Protease inhibitors |
| WO2008078200A2 (en) * | 2006-09-21 | 2008-07-03 | Ambrilia Biopharma Inc. | Protease inhibitors |
| US9296776B2 (en) * | 2007-07-09 | 2016-03-29 | Eastern Virginia Medical School | Substituted nucleoside derivatives with antiviral and antimicrobial properties |
| JO3090B1 (ar) * | 2009-12-11 | 2017-03-15 | Janssen Sciences Ireland Uc | 5- امينو-4- هيدروكسي-بنتويل اميدات |
| TWI513694B (zh) * | 2010-05-11 | 2015-12-21 | Amgen Inc | 抑制間變性淋巴瘤激酶的嘧啶化合物 |
| CA2817368C (en) * | 2010-12-15 | 2019-12-31 | Theravance, Inc. | Neprilysin inhibitors |
| CN103261168B (zh) * | 2010-12-15 | 2015-08-05 | 施万生物制药研发Ip有限责任公司 | 脑啡肽酶抑制剂 |
| JOP20180009A1 (ar) | 2017-02-06 | 2019-01-30 | Gilead Sciences Inc | مركبات مثبط فيروس hiv |
| US12083099B2 (en) | 2020-10-28 | 2024-09-10 | Accencio LLC | Methods of treating symptoms of coronavirus infection with viral protease inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2052907A1 (en) * | 1990-10-11 | 1992-04-12 | Joseph P. Vacca | Hiv protease inhibitors having symmetrical structure |
| WO1992015319A1 (en) * | 1991-03-08 | 1992-09-17 | Smithkline Beecham Corporation | Hiv protease inhibitors |
| TW409125B (en) | 1996-04-22 | 2000-10-21 | Novartis Ag | Antivirally active heterocyclic azahexane derivatives |
| SE9701245D0 (sv) * | 1997-04-04 | 1997-04-04 | Bjoern Classon | Antivirals |
| AU2006212422B2 (en) | 2005-02-10 | 2011-08-18 | Medivir Ab | HIV protease inhibitors |
-
2006
- 2006-02-09 AU AU2006212422A patent/AU2006212422B2/en not_active Ceased
- 2006-02-09 ES ES06723010T patent/ES2326041T3/es active Active
- 2006-02-09 JP JP2007554500A patent/JP2008530045A/ja not_active Withdrawn
- 2006-02-09 KR KR1020077018471A patent/KR20070110847A/ko not_active Ceased
- 2006-02-09 PL PL06723010T patent/PL1851193T3/pl unknown
- 2006-02-09 WO PCT/EP2006/001135 patent/WO2006084688A1/en not_active Ceased
- 2006-02-09 US US11/884,224 patent/US7807677B2/en not_active Expired - Fee Related
- 2006-02-09 EA EA200701692A patent/EA013520B1/ru not_active IP Right Cessation
- 2006-02-09 EP EP06723010A patent/EP1851193B1/en active Active
- 2006-02-09 CA CA002594395A patent/CA2594395A1/en not_active Abandoned
- 2006-02-09 MX MX2007009655A patent/MX2007009655A/es active IP Right Grant
- 2006-02-09 DE DE602006006418T patent/DE602006006418D1/de active Active
- 2006-02-09 BR BRPI0607230-5A patent/BRPI0607230A2/pt not_active IP Right Cessation
- 2006-02-09 AT AT06723010T patent/ATE429417T1/de not_active IP Right Cessation
- 2006-02-09 AP AP2007004079A patent/AP2007004079A0/xx unknown
-
2007
- 2007-06-11 IL IL183850A patent/IL183850A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6524081B2 (ja) | ジヒドロピリミジン化合物及び医薬におけるその適用 | |
| CA2903288C (en) | N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities | |
| ES2426288T3 (es) | Novedoso derivado de imidazol | |
| ES2558512T3 (es) | Compuestos de tetraciclina sustituida con C7-fluoro | |
| AU2019342102B2 (en) | Compounds for treating certain leukemias | |
| USRE49361E1 (en) | Fused bicyclic (hetero)aromatic compounds useful for the treatment of cancers | |
| US12351582B2 (en) | Aurora kinase inhibitors and uses thereof | |
| RU2010114828A (ru) | Производные урацила или тимина для лечения гепатита с | |
| JP2007524696A5 (enExample) | ||
| JP2012528166A5 (enExample) | ||
| JP2013531029A5 (enExample) | ||
| CA2565660A1 (en) | Ortho substituted aryl or heteroaryl amide compounds | |
| JP2010513322A5 (enExample) | ||
| AU2004299413A1 (en) | Novel oxazolidinone derivatives | |
| JP2006524222A5 (enExample) | ||
| NZ603896A (en) | 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatement of alzheimer's disease and other forms of dementia | |
| WO2005105732A8 (en) | Substituted methyl aryl or heteroaryl amide compounds | |
| EA017173B1 (ru) | Способ синтеза соединений, пригодных для лечения гепатита с | |
| TW200600086A (en) | Chemical compound | |
| JP2017511357A5 (enExample) | ||
| JP2008530045A5 (enExample) | ||
| EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
| CN113906026A (zh) | 作为atr激酶抑制剂的2,4,6-三取代的嘧啶化合物 | |
| JP2020516616A5 (enExample) | ||
| US20240327356A1 (en) | Pyrimidine based ras modulators and uses thereof |